Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06469788 · ClinicalTrials.gov registry record · NA
Testimonials and Navigation in Rheumatology
A NA study of Autoimmune Diseases and Rheumatologic Disease, sponsored by University of Alabama at Birmingham.
- Recruiting
- Registry status
- NA
- Development phase
- 1,170
- Enrollment target
- 3
- Study locations
NCT06469788: Recruiting NA study of Autoimmune Diseases and Rheumatologic Disease, sponsored by University of Alabama at Birmingham.
NCT06469788 is a NA study of Autoimmune Diseases and Rheumatologic Disease that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 1,170 participants, above the 932-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (26% higher). The trial reports 3 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06469788, a NA study of Autoimmune Diseases and Rheumatologic Disease, is actively recruiting participants, sponsored by University of Alabama at Birmingham.
- RECRUITING
- Registry status
- NA
- Development phase
- 1,170 participants
- Enrollment target
- 3
- Study locations
Study Summary
The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
Primary Outcome
We will measure rates of receipt of updated COVID-19 vaccination.
Conditions Studied
Interventions
- BEHAVIORAL Patient Navigation
- BEHAVIORAL Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences
- BEHAVIORAL Video on the importance of good oral health for patients with AIRD
- BEHAVIORAL Brochure on COVID-19 vaccination in AIRD patients
- BEHAVIORAL Brochure on the importance of good oral health in AIRD patients
Study Locations (3)
Massachusetts
- Brigham Women's Hospital - Boston
- University of Massachusetts Chan Medical School - Worcester
Alabama
- University of Alabama at Birmingham - Birmingham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,170 participants |
| Start Date | 2024-12-18 |
| Est. Completion | 2027-08-31 |
| Phase | NA |
What NCT06469788 shows while recruiting
NCT06469788 is an interventional study that assigns participants to a tested intervention. Its 1,170 participants enrollment target places it among the larger protocols in the corpus, above the 932-participant average among 25 other Autoimmune Diseases trials with a reported enrollment target (26% higher).
The record links to 2 conditions, with Autoimmune Diseases appearing as the primary indexed condition, and to 5 interventions - of which Patient Navigation is the first listed.
NCT06469788 reports a single indexed study location in Massachusetts, Alabama.
Frequently Asked Questions
What is clinical trial NCT06469788 about?
NCT06469788 is a clinical study titled "Testimonials and Navigation in Rheumatology". The overall goal of this study is to determine whether a novel, multi-modal, patient-directed behavioral intervention initiated in rheumatology clinics is an effective approach to improve uptake of updated COVID-19 vaccine.
What is the current status of trial NCT06469788?
This trial is currently recruiting. It is a NA study. The enrollment target is 1,170 participants. The study started on 2024-12-18. Estimated completion is 2027-08-31.
What conditions does trial NCT06469788 study?
This clinical trial studies the following conditions: Autoimmune Diseases, Rheumatologic Disease.
What interventions are being tested in trial NCT06469788?
The interventions under investigation include: Patient Navigation (BEHAVIORAL), Video comprised of AIRD patient narratives on COVID-19 vaccination thoughts and experiences (BEHAVIORAL), Video on the importance of good oral health for patients with AIRD (BEHAVIORAL), Brochure on COVID-19 vaccination in AIRD patients (BEHAVIORAL), Brochure on the importance of good oral health in AIRD patients (BEHAVIORAL).
Who is sponsoring clinical trial NCT06469788?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06469788 being conducted?
This trial has 3 study locations across Alabama, Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Autoimmune Diseases
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06469788's enrollment target sits among peer trials
1,170 5th of 25 higher than 21 of 25 other Autoimmune Diseases trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Autoimmune Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
VNS Prospective Neuromodulation of Immune and Gastrointestinal Systems
RECRUITING · NA
-
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
ACTIVE NOT RECRUITING · NA
-
Day and Night Closed-loop in Young People With Type 1 Diabetes
COMPLETED · NA
-
Photo-Protection Trial (NB-UVB vs. Placebo) in High-risk Hospitalized COVID-19 Patients
COMPLETED · NA
-
Rheumatology Diet Study
RECRUITING
-
Collection and Distribution of Biospecimens for Novel Research Uses
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04275557 · 1,174 participants
Using Radiogenomics to Predict Malignant Potential of Intraductal Papillary Mucinous Neoplasms of the Pancreas
- NCT07009509 · 1,166 participants · NA
Pilot Study of the YES-CAN! Program to Prevent Youth Nicotine Vaping
- NCT06133322 · 1,176 participants · NA
Blood Pressure Lowering Strategies to Eliminate Hypertension Disparities (BLESSED)
- NCT07237048 · 1,164 participants · Phase 2
Minocycline in Stroke Study at Maimonides
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI